Detalles de la búsqueda
1.
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
Clin Infect Dis;
73(4): 706-715, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34398956
2.
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
AIDS Res Ther;
15(1): 10, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29636106
3.
Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review.
Clin Infect Dis;
65(7): 1226-1228, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575238
4.
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.
Clin Infect Dis;
62(9): 1178-1185, 2016 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908786
5.
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Lancet;
385(9979): 1738-1747, 2015 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795076
6.
Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Trop Med Int Health;
21(9): 1131-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27383454
7.
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.
BMC Infect Dis;
15: 12, 2015 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25582793
8.
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
N Engl J Med;
365(16): 1482-91, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22010914
9.
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
J Infect Dis;
208(4): 662-71, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23687222
10.
Reply to Gupta-Wright et al.
Clin Infect Dis;
66(1): 159, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020258
11.
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
Clin Infect Dis;
57(4): 586-93, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592830
12.
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.
J Infect Dis;
205(11): 1739-44, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22448003
13.
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Clin Infect Dis;
54 Suppl 4: S294-9, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544190
14.
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Clin Infect Dis;
54(11): 1660-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22474222
15.
Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis.
AIDS;
36(10): 1437-1447, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608116
16.
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.
Lancet;
376(9734): 33-40, 2010 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557927
17.
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
J Infect Dis;
201(6): 803-13, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20151839
18.
Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers.
Front Immunol;
12: 781263, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987508
19.
NeuroAIDS in Africa.
J Neurovirol;
16(3): 189-202, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20500018
20.
Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations.
S Afr J Infect Dis;
35(1): 169, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-34485477